BNP Paribas Financial Markets’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $511M | Sell |
|
|||||
2025
Q1 | $637M | Buy |
|
|||||
2024
Q4 | $502M | Sell |
|
|||||
2024
Q3 | $757M | Buy |
|
|||||
2024
Q2 | $324M | Sell |
|
|||||
2024
Q1 | $373M | Buy |
|
|||||
2023
Q4 | $293M | Sell |
|
|||||
2023
Q3 | $358M | Buy |
|
|||||
2023
Q2 | $358M | Buy |
|
|||||
2023
Q1 | $171M | Buy |
|
|||||
2022
Q4 | $181M | Buy |
|
|||||
2022
Q3 | $125M | Sell |
|
|||||
2022
Q2 | $206M | Buy |
|
|||||
2022
Q1 | $136M | Sell |
|
|||||
2021
Q4 | $228M | Sell |
|
|||||
2021
Q3 | $188M | Sell |
|
|||||
2021
Q2 | $189M | Buy |
|
|||||
2021
Q1 | $136M | Buy |
|
|||||
2020
Q4 | $96.2M | Sell |
|
|||||
2020
Q3 | $186M | Buy |
|
|||||
2020
Q2 | $155M | Buy |
|
|||||
2020
Q1 | $74.2M | Sell |
|
|||||
2019
Q4 | $214M | Sell |
|
|||||
2019
Q3 | $213M | Buy |
|
|||||
2019
Q2 | $199M | Buy |
|
|||||
2019
Q1 | $173M | Sell |
|
|||||
2018
Q4 | $200M | Sell |
|
|||||
2018
Q3 | $270M | Sell |
|
|||||
2018
Q2 | $235M | Buy |
|
|||||
2018
Q1 | $177M | Sell |
|
|||||
2017
Q4 | $198M | Sell |
|
|||||
2017
Q3 | $317M | Buy |
|
|||||
2017
Q2 | $271M | Buy |
|
|||||
2017
Q1 | $198M | Buy |
|
|||||
2016
Q4 | $150M | Buy |
|
|||||
2016
Q3 | $52.5M | Buy |
|
|||||
2016
Q2 | $45.3M | Sell |
|
|||||
2016
Q1 | $68.1M | Sell |
|
|||||
2015
Q4 | $186M | Buy |
|
|||||
2015
Q3 | $153M | Buy |
|
|||||
2015
Q2 | $51.6M | Sell |
|
|||||
2015
Q1 | $200M | Buy |
|
|||||
2014
Q4 | $161M | Sell |
|
|||||
2014
Q3 | $186M | Buy |
|
|||||
2014
Q2 | $136M | Sell |
|
|||||
2014
Q1 | $190M | Buy |
|
|||||
2013
Q4 | $140M | Sell |
|
|||||
2013
Q3 | $246M | Buy |
|
|||||
2013
Q2 | $128M | Buy |
|